Pulmonx Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGS:LUNG Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
02 Mar 26	SellUS$11,057	Geoffrey Rose	Individual	7,732	US$1.43
02 Mar 26	SellUS$17,499	David Lehman	Individual	12,237	US$1.43
02 Mar 26	SellUS$96,973	Glendon French	Individual	67,813	US$1.43
02 Mar 26	SellUS$14,991	Srikanth Radhakrishnan	Individual	10,483	US$1.43
01 Dec 25	SellUS$16,136	David Lehman	Individual	10,278	US$1.57
01 Dec 25	SellUS$13,824	Glendon French	Individual	8,805	US$1.57
01 Dec 25	SellUS$9,926	Geoffrey Rose	Individual	6,322	US$1.57
02 Sep 25	SellUS$15,630	David Lehman	Individual	9,769	US$1.60
02 Sep 25	SellUS$10,469	Geoffrey Rose	Individual	6,543	US$1.60
02 Sep 25	SellUS$12,698	Mehul Joshi	Individual	7,936	US$1.60
02 Sep 25	SellUS$15,437	Steven Williamson	Individual	9,648	US$1.60
12 Jun 25	SellUS$25,280	Richard Ferrari	Individual	8,000	US$3.16
05 Jun 25	BuyUS$71,362	Daniel Florin	Individual	23,321	US$3.06
02 Jun 25	SellUS$32,736	David Lehman	Individual	10,457	US$3.14
02 Jun 25	SellUS$21,748	Geoffrey Rose	Individual	6,947	US$3.14
02 Jun 25	SellUS$25,231	Mehul Joshi	Individual	8,061	US$3.13
02 Jun 25	SellUS$31,059	Steven Williamson	Individual	9,923	US$3.13

Insider Trading Volume

Insider Buying: LUNG insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of LUNG?
Owner Type	Number of Shares	Ownership Percentage
Individual Insiders	2,181,092	5.16%
Hedge Funds	2,788,323	6.6%
General Public	7,326,922	17.3%
Institutions	29,940,866	70.9%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 72.1% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
11.2%	PRIMECAP Management Company	4,724,991	US$7.3m	-0.06%	no data
9.22%	Morgan Stanley	3,893,600	US$6.0m	-0.69%	no data
6.6%	Soleus Capital Management, L.P.	2,788,323	US$4.3m	36.8%	0.16%
6.3%	BlackRock, Inc.	2,661,607	US$4.1m	-1.65%	no data
6%	The Vanguard Group, Inc.	2,533,526	US$3.9m	-0.28%	no data
4.6%	ExodusPoint Capital Management, LP	1,943,834	US$3.0m	-0.38%	0.03%
2.76%	Bank of America Corporation	1,166,826	US$1.8m	60.4%	no data
2.76%	Deutsche Asset & Wealth Management	1,163,678	US$1.8m	3.36%	no data
2.3%	Glendon French	971,981	US$1.5m	5.13%	no data
2.24%	Geode Capital Management, LLC	944,492	US$1.5m	4.19%	no data
2.19%	Kent Lake PR LLC	926,157	US$1.4m	0%	0.57%
1.92%	State Street Global Advisors, Inc.	809,116	US$1.3m	-1.47%	no data
1.82%	Stonepine Capital Management LLC	768,288	US$1.2m	58%	0.6%
1.79%	Parkman Healthcare Partners LLC	755,636	US$1.2m	3.83%	0.12%
1.78%	Braidwell LP	752,541	US$1.2m	0%	0.04%
1.62%	Barclays PLC	682,932	US$1.1m	44.6%	no data
0.89%	ADAR1 Capital Management, LLC	374,497	US$580.5k	5.37%	0.03%
0.84%	Northern Trust Global Investments	354,674	US$549.7k	5.2%	no data
0.82%	Srikanth Radhakrishnan	345,736	US$535.9k	981%	no data
0.81%	JP Morgan Asset Management	343,282	US$532.1k	-9.34%	no data
0.81%	AQR Capital Management, LLC	342,461	US$530.8k	491%	no data
0.79%	D. E. Shaw & Co., L.P.	335,074	US$519.4k	-40.3%	no data
0.76%	Renaissance Technologies LLC	320,300	US$496.5k	9.69%	no data
0.68%	Jefferies Financial Group Inc.	285,110	US$441.9k	0%	0.01%
0.63%	CFM Wealth Partners LLC	264,039	US$409.3k	0%	0.05%

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2026/05/24 18:35
End of Day Share Price	2026/05/22 00:00
Earnings	2026/03/31
Annual Earnings	2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Pulmonx Corporation is covered by 11 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Travis Steed	BofA Global Research
William Plovanic	Canaccord Genuity
John Young	Canaccord Genuity